Iron deficiency anemia is a common anemia caused by insufficient iron, leading to reduced hemoglobin production and impaired oxygen transport. It is associated with fatigue, weakness, and shortness of breath, and may result from blood loss, poor intake, or poor absorption.
The European Medicines Agency has approved Shield Therapeutics' FeRACCRU® for adolescents aged 12 and older, following FDA approval of ACCRUFeR® for children 10+. The expansion was supported by Phase 3 pediatric trial data showing efficacy and safety in children as young as 1 month.
A nationwide survey reveals 50% of Americans don't know colorectal cancer can be screened at home, as the disease becomes the leading cause of cancer death in adults under 50. Current guidelines recommend screening begin at age 45.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07753031 |
Non-Interventional Study of Ferretab® Comp. (Ferrous Fumarate + Folic Acid Prolonged-Release Capsules) Effects in Adult Patients With Iron Deficiency Anemia and Cardiovascular Disease |
NOT_YET_RECRUITING | |
| NCT07657455 |
Daily Versus Alternate-Day Oral Iron Therapy for Anemia in Second-Trimester Pregnancy |
NOT_YET_RECRUITING | NA |
| NCT07633262 |
FACE-APPS-Based Approach for Improving Iron Deficiency Anaemia Indicators Among Female Adolescents at Marginalized Communities |
RECRUITING | NA |
| NCT07605676 |
Acupoint TENS vs Resistance Training for Iron Deficiency Anemia |
RECRUITING | PHASE4 |
| NCT07483645 |
Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Anemia. |
ACTIVE_NOT_RECRUITING | |
| NCT07397572 |
Iron Supplementation and Anemia After Sleeve Gastrectomy |
RECRUITING | |
| NCT07391371 |
Alternate-day Versus Daily Oral Iron Therapy in Children With Iron Deficiency Anaemia |
NOT_YET_RECRUITING | PHASE4 |
| NCT07287371 |
Sucrosomial Vs Intravenous Iron for Preoperative Anemia |
NOT_YET_RECRUITING | PHASE4 |
| NCT07267975 |
Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing |
COMPLETED | PHASE3 |
| NCT07238972 |
Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery |
NOT_YET_RECRUITING | PHASE4 |
